LPS-binding protein and IL-6 Mark paradoxical tuberculosis immune reconstitution inflammatory syndrome in HIV patients

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Goovaerts, Odin ^a,b   Jennes, Wim ^a   Massinga Loembé, Marguerite ^a,c,d   Ceulemans, Ann ^a   Worodria, William ^e,f,g,m   Mayanja Kizza, Harriet ^e,f,h,m   Colebunders, Robert ^a,b   Kestens, Luc ^a,b   Mascart, Francoise ⁱ   Van Den Bergh, Rafael ^j,k   Locht, Camille ^l   Reiss, Peter ^m   Cobelens, Frank ^m   Ondoa, Pascale ^m   Pakker, Nadine ^g,m   Mugerwa, Roy ^g  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c ALBERT SCHWEITZER HOSPITAL   (Gabon)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e MULAGO HOSPITAL   (Uganda)

^f MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^g Infectious Diseases Network for Treatment and Research in Africa INTERACT   (Uganda)

^h Joint Clinical Research Centre   (Uganda)

ⁱ UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^j DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^k VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^l INSTITUT PASTEUR DE LILLE   (France)

^m ACADEMIC MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN ANTIBODY; FATTY ACID BINDING PROTEIN 2; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LIPOPOLYSACCHARIDE BINDING PROTEIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INNATE IMMUNITY; MALE; MIXED INFECTION; PARADOXICAL TUBERCULOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TUBERCULOSIS;

ACUTE-PHASE PROTEINS; ADULT; ANTI-HIV AGENTS; BIOLOGICAL MARKERS; CARRIER PROTEINS; FEMALE; HIV INFECTIONS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MEMBRANE GLYCOPROTEINS; PROSPECTIVE STUDIES; TUBERCULOSIS; UGANDA;

EID: 84896732012     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081856     Document Type: Article

References (40)

1. World Health Organisation (WHO) (2011) TB/HIV FACTS.
2. Müller M, Wandel S, Colebunders R, Attia S, Furrer H et al. (2010) Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 10: 251-261. doi:10.1016/S1473-3099(10)70026-8. PubMed: 20334848.
3. Meintjes G, Lawn SD, Scano F, Maartens G, French MA et al. (2008) Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 8: 516-523. doi:10.1016/S1473-3099(08)70184-1. PubMed: 18652998. (Pubitemid 352005824)
4. Burman W, Weis S, Vernon A, Khan A, Benator D et al. (2007) Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis 11: 1282-1289. PubMed: 18229435.
5. Murdoch DM, Venter WD, Van Rie A, Feldman C (2007) Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 4: 9. doi:10.1186/1742-6405-4-9. PubMed: 17488505.
6. Worodria W, Conesa-Botella A, Kisembo H, McAdam KP, Colebunders R (2009) Coping with TB immune reconstitution inflammatory syndrome. Expert Rev Respir Med 3: 147-152. doi:10.1586/ers.09.8. PubMed: 20477308.
7. Conesa-Botella A, Loembé MM, Manabe YC, Worodria W, Mazakpwe D et al. (2011) Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome. J Acquir Immune Defic Syndr, 58: 463-8. PubMed: 21963941.
8. Worodria W, Massinga-Loembe M, Mazakpwe D, Luzinda K, Menten J et al. (2011) Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr 58: 32-37. doi:10.1097/QAI.0b013e3182255dc2. PubMed: 21654499.
9. Barber DL, Andrade BB, Sereti I, Sher A (2012) Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none. Nat Rev Microbiol 10: 150-156. PubMed: 22230950.
10. French MA (2007) Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy. Curr HIV/AIDS Rep 4: 16-21. doi:10.1007/s11904-007-0003-z. PubMed: 17338856. (Pubitemid 46555247)
11. Ruhwald M, Ravn P (2007) Immune reconstitution syndrome in tuberculosis and HIV-co-infected patients: Th1 explosion or cytokine storm? AIDS 21: 882-884. doi:10.1097/QAD.0b013e3280b079c8. PubMed: 17415049. (Pubitemid 46573166)
12. Grant PM, Komarow L, Lederman MM, Pahwa S, Zolopa AR et al. (2012) Elevated Interleukin 8 and T-Helper 1 and T-Helper 17 Cytokine Levels Prior to Antiretroviral Therapy in Participants Who Developed Immune Reconstitution Inflammatory Syndrome During ACTG A5164. J Infect Dis .
13. Antonelli LR, Mahnke Y, Hodge JN, Porter BO, Barber DL et al. (2010) Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood 116: 3818-3827. doi:10.1182/blood-2010-05-285080. PubMed: 20660788.
14. Van Den Bergh R, Vanham G, Raes G, De Baetselier P, Colebunders R (2006) Mycobacterium-associated immune reconstitution disease: macrophages running wild? Lancet Infect Dis 6: 2-3. doi:10.1016/S1473-3099(05)70302-9. PubMed: 16377524.
15. Stone SF, Price P, Keane NM, Murray RJ, French MA (2002) Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART. HIV Med 3: 21-27. doi:10.1046/j.1464-2662. 2001.00096.x. PubMed: 12059947. (Pubitemid 34189592)
16. Conesa-Botella A, Meintjes G, Coussens AK, van der Plas H, Goliath R et al. (2012) Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-TB immune reconstitution inflammatory syndrome (TB-IRIS). Clin Infect Dis.
17. Tadokera R, Meintjes G, Skolimowska KH, Wilkinson KA, Matthews K et al. (2011) Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J 37: 1248-1259. doi:10.1183/09031936. 00091010. PubMed: 20817712.
18. Narendran G, Andrade BB, Porter BO, Chandrasekhar C, Venkatesan P et al. (2013) Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction. PLOS ONE 8: e63541. doi:10.1371/journal.pone.0063541. PubMed: 23691062.
19. Porter BO, Ouedraogo GL, Hodge JN, Smith MA, Pau A et al. (2010) d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS. Clin Immunol 136: 42-50. doi:10.1016/j.clim.2010.02.010. PubMed: 20227921.
20. Haddow LJ, Dibben O, Moosa MY, Borrow P, Easterbrook PJ (2011) Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 25: 1163-1174. doi:10.1097/QAD.0b013e3283477d67. PubMed: 21505297.
21. Meintjes G, Wilkinson KA, Rangaka MX, Skolimowska K, van VK et al. (2008) Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med 178: 1083-1089. doi:10.1164/rccm.200806-858OC. PubMed: 18755923.
22. Brenchley JM, Douek DC (2008) The mucosal barrier and immune activation in HIV pathogenesis. Curr Opin HIV AIDS 3: 356-361. doi: 10.1097/COH. 0b013e3282f9ae9c. PubMed: 19372990. (Pubitemid 351521021)
23. Elsing C, Ernst S, Kayali N, Stremmel W, Harenberg S (2011) Lipopolysaccharide binding protein, interleukin-6 and C-reactive protein in acute gastrointestinal infections: value as biomarkers to reduce unnecessary antibiotic therapy. Infection 39: 327-331. doi:10.1007/s15010-011-0117-5. PubMed: 21523403.
24. Kitchens RL, Thompson PA (2005) Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 11: 225-229. doi: 10.1179/096805105X46565. PubMed: 16176659. (Pubitemid 41358857)
25. Sandler NG, Wand H, Roque A, Law M, Nason MC et al. (2011) Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 203: 780-790. doi:10.1093/infdis/jiq118. PubMed: 21252259.
26. Yu W, Soprana E, Cosentino G, Volta M, Lichenstein HS et al. (1998) Soluble CD14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay. J Immunol 161: 4244-4251. PubMed: 9780199. (Pubitemid 28469007)
27. Juffermans NP, Verbon A, van Deventer SJ, Buurman WA, van DH et al. (1998) Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis. J Infect Dis 178: 1839-1842. doi:10.1086/314492. PubMed: 9815247. (Pubitemid 28558167)
28. Worodria W, Menten J, Massinga-Loembe M, Mazakpwe D, Bagenda D et al. (2012) Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection. Antivir Ther, 17: 841-8. PubMed: 22543224.
29. Worodria W, Massinga-Loembe M, Mayanja-Kizza H, Namaganda J, Kambugu A et al. (2011) Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART. Clin Dev Immunol 2011: 758350
30. World Health Organisation (WHO) (2012) Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-contstrained settings.
31. Dentener MA, Von Asmuth EJ, Francot GJ, Marra MN, Buurman WA (1993) Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide. J Immunol 151: 4258-4265. PubMed: 8409400. (Pubitemid 23298759)
32. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371. PubMed: 17115046. (Pubitemid 44924494)
33. Bukh AR, Melchjorsen J, Offersen R, Jensen JM, Toft L et al. (2011) Endotoxemia is associated with altered innate and adaptive immune responses in untreated HIV-1 infected individuals. PLOS ONE 6: e21275. doi:10.1371/journal. pone.0021275. PubMed: 21731690.
34. Mavigner M, Cazabat M, Dubois M, L'Faqihi FE, Requena M et al. (2012) Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J Clin Invest 122: 62-69. doi:10.1172/ JCI59011. PubMed: 22156200.
35. Boulware DR, Meya DB, Bergemann TL, Wiesner DL, Rhein J et al. (2010) Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med 7: e1000384. PubMed: 21253011.
36. Natarajan K, Kundu M, Sharma P, Basu J (2011) Innate immune responses to M. tuberculosis infection. Tuberculosis (Edinb) 91: 427-431. doi:10.1016/j.tube.2011.04.003.
37. Anas A, van der Poll T, de Vos AF (2010) Role of CD14 in lung inflammation and infection. Crit Care 14: 209. doi:10.1186/cc9332. PubMed: 20236452.
38. Hallatschek W, Fiedler G, Kirschning CJ, Creutzburg F, Lamping N et al. (2004) Inhibition of hepatic transcriptional induction of lipopolysaccharide- binding protein by transforming-growth-factor beta 1. Eur J Immunol 34: 1441-1450. doi:10.1002/eji.200324874. PubMed: 15114678. (Pubitemid 39256024)
39. Skinner NA, MacIsaac CM, Hamilton JA, Visvanathan K (2005) Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens. Clin Exp Immunol 141: 270-278. doi:10.1111/j.1365-2249. 2005.02839.x. PubMed: 15996191. (Pubitemid 41003351)
40. Oliver BG, Elliott JH, Price P, Phillips M, Saphonn V et al. (2010) Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. J Infect Dis 202: 1728-1737. doi:10.1086/657082. PubMed: 20977362.